High-Throughput Agonist Shift Assay Development for the Analysis of M1-Positive Allosteric Modulators. (September 2017)

• Record Type: Journal Article
• Authors: Homsher, Michelle F.; Beshore, Douglas C.; Cassaday, Jason; Squadroni, Brian; Mohammed, Elizabeth; Hartnett, Michelle; Day, Stephen; Ma, Lei; Pechter, David; Smith, Michelle D.; Monsma, Fredrick; Zuck, Paul; Finley, Michael F.; Uebele, Victor N.; Hermes, Jeffrey D.
• Is Part Of: SLAS discovery. Volume 22:Number 8(2017)
• Page Start: 1060
• Page End: 1066
• Publication Date: 2017-09
• Subjects: agonist shift -- muscarinic -- M1 PAM -- allostery -- allosteric modulator; Drugs -- Analysis -- Periodicals; Drugs -- Testing -- Periodicals; Biomolecules -- Analysis -- Periodicals; Biomolecules -- Analysis; Drugs -- Analysis; Drugs -- Testing; Drug Evaluation, Preclinical; Molecular Biology -- methods; Periodicals; Periodicals; 615.1
• DOI: 10.1177/2472555217705373
• Languages: English
• ISSNs: 2472-5552

Abstract

Agonist shift assays feature cross-titrations of allosteric modulators and orthosteric ligands. Information generated in agonist shift assays can include a modulator's effect on the orthosteric agonist's potency (alpha) and efficacy (beta), as well as direct agonist activity of the allosteric ligand (tauB) and the intrinsic binding affinity of the modulator to the unoccupied receptor (KB). Because of the heavy resource demand and complex data handling, these allosteric parameters are determined infrequently during the course of a drug discovery program and on a relatively small subset of compounds. Automation of agonist shift assays enables this data-rich analysis to evaluate a larger number of compounds, offering the potential to differentiate compound classes earlier and prospectively prioritize based on desired molecular pharmacology. A high-throughput calcium-imaging agonist shift assay was pursued to determine the allosteric parameters of over 1000 positive allosteric modulator (PAM) molecules for the human muscarinic acetylcholine receptor 1 (M1 ). Control compounds were run repeatedly to demonstrate internal consistency. Comparisons between potency measurements and the allosteric parameter results demonstrate that these different types of measurements do not necessarily correlate, highlighting the importance of fully characterizing and understanding the allosteric properties of leads.